How Can We Help You?

There may be options to help you afford Tarceva, no matter what type of health insurance you have.

Referrals to Independent Co-pay Assistance Foundations

If you need help with the co-pay for Tarceva, Tarceva Access Solutions can refer you to an independent co-pay assistance foundation.

An independent co-pay assistance foundation is a charitable organization that gives financial assistance for medicines.

Call Tarceva Access Solutions at (888) 249-4918 for a referral.

If you would like to contact a foundation directly, you can use the information below:

No funds are available at this time.

Please call Genentech Access Solutions at (866) 4ACCESS /
(866) 422-2377. We may be able to help.

CancerCare Co-Payment Assistance Foundation
275 Seventh Avenue, 22nd Floor 
New York, NY 10001
866-55-COPAY (866-552-6729)
www.cancercarecopay.org

Independent co-pay assistance foundations have their own rules for eligibility. We cannot guarantee a foundation will help you. We only can refer you to a foundation that supports your disease state. This information is provided as a resource for you. We do not endorse or show financial preference for any particular foundation. The foundations in this list are not the only ones that might be able to help you.

Referrals to the Genentech® Access to Care Foundation

The Genentech Access to Care Foundation, or GATCF, can help you receive Tarceva free of charge, if you qualify.

GATCF helps people who are:

  • Uninsured—People who do not have insurance
  • Rendered uninsured—People whose health insurance does not cover their medicine
  • Underinsured—People who have health insurance (including commercial or government insurance plans), but pay more than a certain amount for Tarceva each year

Other eligibility criteria must be met to qualify for free medicine from GATCF. You might qualify if you meet the requirements below.

  • Do you have health insurance?

  • Is your yearly household income less than $100,000?

  • Is your yearly household income less than $150,000?

  • Do you spend 5% or more of your yearly household income on the out-of-pocket costs for Tarceva?

You Might Qualify for Free Medicine From GATCF

To apply for GATCF, you’ll need to complete the PAN form and your doctor’s office will need to complete the SMN form.

Be sure to fill out Sections 5 and 6 on the PAN form.

Download the SMN and PAN

Other Options May Be Available

You do not appear to qualify for free medicine from GATCF. However, other patient assistance options may be available to help you.

Find Out Which Option May Be Right for You

You can also call Tarceva Access Solutions at (888) 249-4918 and speak with one of our Specialists.

You have to fill out Sections 5 and 6 of the PAN form to apply for GATCF.

If you have health insurance, you must have already tried other types of patient assistance to qualify for free medicine from GATCF. This includes the Genentech BioOncology Co-pay Card and support from independent co-pay assistance foundations. You must also meet financial criteria. If you do not have insurance, you must meet different financial criteria.

Referrals to the Genentech BioOncology Co-pay Card

Tarceva Access Solutions can refer you to the Genentech BioOncology Co-pay Card. It can help you with the out-of-pocket costs for Tarceva, if you’re eligible.

The Genentech BioOncology Co-pay Card helps patients with commercial health insurance. This might be a plan you get through your employer or one you purchased through a Health Insurance Marketplace like HealthCare.gov. To qualify, you must also meet other criteria.

In order to be eligible for the Genentech BioOncology Co-pay Card, the patient must have commercial insurance, must not have Medicare, Medicaid or other government insurance, and must meet other eligibility criteria. They also must agree to the rules set forth in the terms and conditions for the program. Please visit CopayAssistanceNow.com for the full list of terms and conditions.

How to Work With Tarceva Access Solutions

Step 1

Enroll in Tarceva Access Solutions.

How do I enroll?

Step 2

We work with you, your doctor’s office, your health insurance plan and your specialty pharmacy. We might contact you for more information.

What will we find out?

Step 3

We refer you to patient assistance options.

What options are there?

PAN=Patient Authorization and Notice of Request for Transmission of Health Information to Genentech Access Solutions and Genentech® Access to Care Foundation.

SMN=Statement of Medical Necessity.

Important Safety Information & Indication

What it Treats

Who is Tarceva (erlotinib) for?

  • Tarceva is prescribed for patients with non-small cell lung cancer (NSCLC) whose cancer has spread to other parts of the body and that has certain types of epidermal growth factor receptor (EGFR) mutations. Your healthcare provider will perform a test to make sure that Tarceva is right for you.
  • Tarceva is not meant to be used at the same time as certain types of chemotherapy for NSCLC.
  • It is not known if Tarceva is safe and effective in EGFR mutations other than those included in the FDA-approved prescribing information.

Tarceva is approved for advanced-stage pancreatic cancer.

  • Tarceva in combination with gemcitabine is prescribed for patients with advanced-stage pancreatic cancer whose cancer has spread, grown, or cannot be surgically removed and who have not received previous chemotherapy.

Important Safety Information

Contact your HCP right away if you experience any of the side effects listed below.

What are the possible side effects of Tarceva?

Tarceva can cause serious side effects, including:

  • Lung problems (called interstitial lung disease [ILD] events). Tarceva has been shown to cause lung problems, including death. Symptoms of lung problems may include shortness of breath, cough, and fever. Tarceva may need to be stopped if you have any of these symptoms.
  • Liver and kidney problems. Tarceva has been shown to cause severe kidney and liver problems, including death. Some people had their kidneys and liver stop working. Let your HCP know if you have a history of liver or kidney disease.
  • Stomach and intestinal problems (called gastrointestinal [GI] perforation). Tarceva has been shown to cause GI perforation, which has led to death. A GI perforation is a hole that develops in your stomach or intestine. Tarceva patients may be at a higher risk for GI perforation if they:
    • Are taking medicines including those that may help block the growth of blood vessels; steroids; non-steroidal anti-inflammatory drugs (NSAIDs); and certain chemotherapies. Always tell your HCP about any medicines you are taking.
    • Have a history of ulcers or other stomach disease.
  • Serious skin conditions. Tarceva has been shown to cause blistering and skin peeling. This may result in other serious skin disorders or death.
  • Blood, bleeding, and clotting problems. Tarceva has been shown to cause certain blood problems and other bleeding and clotting problems. These have led to stroke and death.
  • Eye disorders. Tarceva has been shown to cause dry eyes, unusual eyelash growth, or swelling of the cornea. The cornea is the clear coating of the eyeball. This swelling may irritate or damage the eye.
  • Bleeding events when taking warfarin with Tarceva. Tell your HCP if you are taking a blood thinner, such as warfarin. Taking Tarceva with this medicine can cause death.
  • Pregnancy. Tarceva can harm an unborn baby. Women should use effective birth control during treatment and for at least 1 month after the last dose of Tarceva. Tell your HCP if you have become pregnant, or if you think you may be pregnant, during treatment with Tarceva. Do not breast-feed during treatment with Tarceva and for 2 weeks after the final dose.

When should I call my HCP while taking Tarceva?

Call your HCP if you have:

  • Serious or ongoing diarrhea, nausea (feeling sick to your stomach), loss of appetite, or vomiting.
  • New or worsening shortness of breath or cough.
  • Eye irritation.
  • New or worsening rash, blistering, or peeling of the skin.
  • Any changes in smoking habits.

What are some of the most common side effects of Tarceva?

  • In 1st-line NSCLC treatment: Diarrhea, weakness, rash, cough, shortness of breath, loss of appetite (not wanting to eat).
  • In maintenance/2nd- or 3rd-line NSCLC treatment: Rash and diarrhea.
  • In pancreatic cancer treatment: Fatigue (feeling very tired), rash, nausea, loss of appetite, diarrhea.

What should I know about skin (including rash), hair, and nail problems or diarrhea while taking Tarceva?

  • Skin (including rash):
    • While taking Tarceva, rash could happen or get worse if the skin is exposed to the sun. You may want to use alcohol-free lotions and sunscreens or avoid being out in the sun.
    • Your skin and nails may get darker. You may also have dry skin that may or may not crack. This most often happens with rash.
    • Talk with your HCP if you notice a rash. He or she may be able to help you manage it.
  • Hair and nails: Hair and nail problems have been seen in patients taking Tarceva. These include increased hairiness and brittle or loose nails.
  • Diarrhea: Diarrhea can usually be treated with anti-diarrhea medicine. Your HCP can help you find the right medicine for you.

What should I do if I am taking or am prescribed other medicines or supplements while taking Tarceva?

  • Always tell your HCP about all of the medicines and herbal supplements you are taking.
  • DO NOT start taking any new medicines or herbal supplements before talking with your HCP.
  • DO NOT eat grapefruit or drink grapefruit juice before talking with your HCP.

Will smoking affect my treatment with Tarceva?

  • If you smoke, you should stop smoking before you start treatment with Tarceva.
  • If you continue to smoke, your treatment with Tarceva may need to be adjusted. Talk with your HCP if you continue to smoke.

Always talk with your HCP about any side effects you may have with Tarceva.

You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

 

Please see the Tarceva full Product Information at www.tarceva.com for additional Important Safety Information.